| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR1800019170 |
Tianjin first center hospital |
B cell malignancies |
Therapy Study |
Premarket |
2018-10-29 | 1531 | Patient list |
| ChiCTR-INR-17011403 |
Department of Hematology, Tianjin First Center Hospital |
Hematological disease |
Therapy Study |
Premarket |
2017-05-17 | 1524 | Patient list |
| ChiCTR-IPR-16008578 |
Tianjin First Center Hospital |
|
Therapy Study |
Post-market |
2016-06-01 | 1705 | Patient list |